This Policy on Board Diversity (the “Policy”) for the Board of Directors (the “Board”) of Thyrocare Technologies Limited (the “Company”) sets out the approach to be followed by the Company to ensure Diversity of the Board. This policy has been formulated by the Nomination and Remuneration Committee (“NRC”) in accordance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI (LODR) Regulations, 2015”) to assure that the Board is fully diversified and comprises of an ideal combination of Executive and Non-Executive Directors, including Independent Directors, with diverse backgrounds.

2.PURPOSE:

The Policy is framed to address the importance of a diverse Board in harnessing the unique and individual skills and experiences of various Members of the Board in such a way that it collectively benefits the business and the Company as whole. The basic  purpose of the Policy is to provide a  basis for leveraging on the diverse knowledge and expertise of the members of the Board so that the Company is able to derive the benefit of diverse points of view and decide on the approach that will be most appropriate in the given situation.

3.LAW AND APPLICABILITY

As per Regulation 19 (4) read with Clause A of Part D of the Schedule II of the SEBI (LODR) Regulations, 2015, NRC of the Company has  devised this Policy on Board Diversity.

The Policy is applicable to the composition of the Board only and does not apply to diversity in relation to the employees of the Company.

4.POLICY STATEMENT:

The Company aims to enhance the effectiveness of the Board by diversifying its composition so that the Company get the benefit out of such diversity in better and improved decision making.

In order to ensure such diversity, the Company shall consider a number of factors, including but not limited to gender, age, cultural and educational background, ethnicity, professional expertise, length of service in his/her profession, and ability to offer unbiased advice.

In order to ensure a balanced composition of executive, non-executive and independent directors on the Board, the Company shall consider candidates from different backgrounds, without any discrimination whatsoever.

5.ROLE OF THE NOMINATION AND REMUNERATION COMMITTEE:

The NRC, inter alia, is responsible for reviewing and assessing the composition of the Board as well as for identifying and recommending appropriately qualified candidature(s), to hold Directorship in the Company, to the Board of Directors where and if need be.

6.REVIEW OF THE POLICY:

The NRC may review the policy whenever it deems fit, to ensure the effectiveness of the Policy, and may revise at its discretion.

7.DISCLOSURE OF THE POLICY:

The Company may disclose this Policy on its website i.e. www.thyrocare.com.The necessary disclosure, if any, about the policy will also be made as per the requirements of SEBI (LODR) Regulations, 2015 and other applicable laws.